Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis
CHENGDU, China, Dec. 23, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of...
Jianpu Technology Inc. Extends Its Share Repurchase Program
BEIJING, Dec. 23, 2024 /PRNewswire/ -- Jianpu Technology Inc. ("Jianpu," or the "Company") (OTCQB: AIJTY), a leading open financial technology platform in China, today announced that its board of directors (the "Board") has approved an extension of...
Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
SAN FRANCISCO and SUZHOU, China, Dec. 20, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...
Macao breaks new ground in practice of "one country, two systems"
BEIJING, Dec. 18, 2024 /PRNewswire/ -- A report from People's Daily: Over the past 25 years since Macao's return to China, the practice of "one country, two systems" with Macao characteristics has achieved remarkable success, thanks to the Chinese...
Global Times: Macao Science-1 a successful example of 'one country, two systems' advantage
BEIJING, Dec. 17, 2024 /PRNewswire/ -- The successful launch of Macao Science-1 satellites, the first space science satellite program jointly developed by the Chinese mainland and Macao, owes much to the strong support of scientists and engineers...
Thailand BOI Approves 10.5 Billion Baht Investment by Foxsemicon Integrated Technology's Subsidiary to Make High-Precision Machinery Parts and Equipment for Semiconductor Sector
BANGKOK, Dec. 11, 2024 /PRNewswire/ -- The Thailand Board of Investment (BOI) today announced it has granted investment privileges to a 10.5 billion baht (ca. US$ 306 million) investment by UNIQUE Integrated Technology Co., Ltd., a subsidiary of...
JinkoSolar Upsizes and Extends Share Repurchase Program
SHANGRAO, China, Dec. 11, 2024 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that its board of directors...
Skyhawk Therapeutics Receives Australian Regulatory Approval to Extend SKY-0515 Treatment Duration in Phase 1 Huntington's Disease Patient Trial
Australian Human Research Ethics Committees approves SKY-0515 treatment for up to 12 weeks in the company's ongoing Phase 1 trial in patients with Huntington's Disease Volumetric MRI measurement is also approved as exploratory study endpoint BOSTON,...
China NMPA approves Simcere's Sanbexin® sublingual tablets for the treatment of Acute Ischemic Stroke
NANJING, China, Dec. 4, 2024 /PRNewswire/ -- On November 2, 2024, Simcere Pharmaceutical announced that Sanbexin® sublingual tablets (generic name: edaravone and dexborneol sublingual tablets), an innovative drug for stroke, has been approved for...
Breathe Easy This Pollen Season with Coway's Sensitive Choice Approved Air Purifiers
The National Asthma Council Australia's Sensitive Choice program has recognised Coway's Airmega air purifier lineup as being Sensitive Choice approved with the potential to benefit people living with asthma and allergies. Amid peak allergy season,...